---
document_datetime: 2025-12-19 12:16:54
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/tuzulby-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: tuzulby-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.6650736
conversion_datetime: 2026-01-03 12:33:45.794821
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Tuzulby

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                    | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | B.II.e.5.a Change in the number of units | 19/12/2025                          |                                             | SmPC,                            |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000314054                     | (e.g. tablets, ampoules, etc.) in a pack - B.II.e.5.a.2 Change outside the range of the currently approved pack sizes - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            | Labelling and PL   |                                                                                                                                                                                                   |
|---------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Variation type IB / EMA/VR/0000303608 | C.I.3 Change(s) in the Summary of Product Characteristics, Labelling or Package Leaflet of human medicinal products intended to implement the outcome of a procedure concerning PSUR or PASS, or the outcome of the assessment done by the competent authority under Articles 45 or 46 of Regulation 1901/2006 - C.I.3.z Implementation of wording agreed by the competent authority + QRD update - Accepted C.I.3.z (Type IB) - To update Sections 4.4 and 4.8 of the SmPC and Sections 2 and 4 of the PL to implement the wording agreed by the PRAC following the outcome of the PSUR procedure EMEA/H/C/PSUSA/00002024/202410. In addition, the MAH took the opportunity to implement editorial changes to update the contact details of the local representatives in NL and AT. Furthermore, the PI in DE was updated to correct typographical errors, the PI in FI was updated to correct a translation error in Section 4.4 of the SmPC, and the PI in DK was updated to correct the term used | 04/11/2025 | SmPC and PL        | To update Sections 4.4 and 4.8 of the SmPC and Sections 2 and 4 of the PL to implement the wording agreed by the PRAC following the outcome of the PSUR procedure EMEA/H/C/PSUSA/00002024/202410. |

<div style=\"page-break-after: always\"></div>

|                                       | request from the Danish authority.                                                                                      |            |     |
|---------------------------------------|-------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000286644 | C.I HUMAN AND VETERINARY MEDICINAL PRODUCTS - C.I.z Other variation - Accepted C.I.z - to submit the updated ERA Report | 08/08/2025 | N/A |